Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials
Authors
Keywords
-
Journal
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-10-25
DOI
10.1681/asn.0000000000000248
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dapagliflozin and All-Cause Hospitalizations in Patients With Heart Failure With Preserved Ejection Fraction
- (2023) Muthiah Vaduganathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial
- (2023) Meir Schechter et al. Lancet Diabetes & Endocrinology
- Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study
- (2022) Silvia J. Leon et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Stopping versus continuing renin–angiotensin–system inhibitors after acute kidney injury and adverse clinical outcomes: an observational study from routine care data
- (2022) Roemer J Janse et al. Clinical Kidney Journal
- Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials
- (2022) Brendon L. Neuen et al. CIRCULATION
- Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
- (2022) João Pedro Ferreira et al. EUROPEAN HEART JOURNAL
- Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease
- (2022) Sunil Bhandari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease
- (2022) Meir Schechter et al. ANNALS OF INTERNAL MEDICINE
- Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
- (2022) Colin Baigent et al. LANCET
- Empagliflozin in Patients with Chronic Kidney Disease
- (2022) NEW ENGLAND JOURNAL OF MEDICINE
- Adverse clinical outcomes associated with RAAS inhibitor discontinuation: analysis of over 400 000 patients from the UK Clinical Practice Research Datalink (CPRD)
- (2021) Toby J L Humphrey et al. Clinical Kidney Journal
- Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure
- (2021) João Pedro Ferreira et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis
- (2021) Kent Y. Feng et al. DIABETES OBESITY & METABOLISM
- Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial
- (2021) Brendon L Neuen et al. EUROPEAN HEART JOURNAL
- Prescription Practices in Patients With Mild to Moderate CKD in India
- (2021) Narayan Prasad et al. Kidney International Reports
- Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate
- (2020) Yao Qiao et al. JAMA Internal Medicine
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study
- (2020) Edouard L. Fu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Stopping RAS Inhibitors to Minimize Acute Kidney Injury
- (2019) Charles Tomson et al. Clinical Journal of the American Society of Nephrology
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United States
- (2019) Daniel P. Murphy et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age
- (2019) J. Ariana Noel et al. JAMA Internal Medicine
- SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
- (2019) Brendon L Neuen et al. Lancet Diabetes & Endocrinology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started